Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Fulcrum Therapeutics (FULC) Asset Utilization Ratio: 2020-2024

Historic Asset Utilization Ratio for Fulcrum Therapeutics (FULC) over the last 3 years, with Jun 2024 value amounting to 0.31.

  • Fulcrum Therapeutics' Asset Utilization Ratio rose 3098.38% to 0.31 in Q2 2024 from the same period last year, while for Jun 2024 it was 0.31, marking a year-over-year increase of 3098.38%. This contributed to the annual value of 0.31 for FY2024, which is 2564.82% up from last year.
  • Latest data reveals that Fulcrum Therapeutics reported Asset Utilization Ratio of 0.31 as of Q2 2024, which was up 2,895.85% from 0.01 recorded in Q4 2023.
  • Over the past 5 years, Fulcrum Therapeutics' Asset Utilization Ratio peaked at 0.31 during Q2 2024, and registered a low of 0.01 during Q3 2023.
  • For the 3-year period, Fulcrum Therapeutics' Asset Utilization Ratio averaged around 0.06, with its median value being 0.03 (2022).
  • Per our database at Business Quant, Fulcrum Therapeutics' Asset Utilization Ratio plummeted by 85.94% in 2023 and then soared by 3,098.38% in 2024.
  • Quarterly analysis of 5 years shows Fulcrum Therapeutics' Asset Utilization Ratio stood at 0.06 in 2020, then grew by 20.34% to 0.08 in 2021, then crashed by 65.79% to 0.03 in 2022, then plummeted by 60.89% to 0.01 in 2023, then spiked by 3,098.38% to 0.31 in 2024.
  • Its Asset Utilization Ratio stands at 0.31 for Q2 2024, versus 0.01 for Q4 2023 and 0.01 for Q3 2023.